Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Materials (Basel) ; 16(17)2023 Aug 28.
Article in English | MEDLINE | ID: mdl-37687584

ABSTRACT

During the processing of thermoplastics, polymers are subjected to high stress. As a result of this stress, the polymer chains break, leading to a lower molar mass. This further leads to a lower viscosity of the plastic melt and, eventually, to poorer mechanical properties of the manufactured plastic product. Especially in the context of recycling plastics, this poses a challenge to process technology and product properties. This work aims is to provide a prediction of the material degradation under known stress, so that, for example, a process design that is gentle on the material can be carried out. In order to be able to predict material degradation under a load, a test stand for defined material degradation was designed. The test stand allows for material damaging under a defined temperature, shear rate and residence time. At the same time, the test stand can be used to measure the viscosity, which is used to describe the degradation behavior, since the viscosity correlates with the molar mass. The measured decrease in viscosity under stress can be used to predict material damage under the influencing variables of temperature, shear rate and residence time by means of a test plan and a suitable mathematical description of the measured data. The mathematical description can thus be integrated into simulation environments for plastics processing, so that a simulation of the material degradation can be carried out, if necessary also taking the viscosity reduction into account.

2.
Polymers (Basel) ; 15(4)2023 Feb 19.
Article in English | MEDLINE | ID: mdl-36850316

ABSTRACT

In the context of plastics recycling, plastics are processed several times. With each new melting and extrusion the plastic is damaged, which can have a negative effect on product properties. To counteract material damage, special additives such as chain extenders can be used, which are intended to lead to post-polymerization during processing. A linear chain extension is important here, as branching and crosslinking can lead to uncontrolled changes in the plastic's properties. To investigate the suitability of specialized linear chain extenders for polyamides, a polyamide-6 was processed several times and the molar mass distribution was evaluated after each extrusion cycle. Three series of tests were carried out. First, the plastic was regranulated five times without additives and twice with different concentrations of chain extenders on a twin-screw extruder. The results of the study show that not only can molar mass degradation be prevented with the appropriate additive, it is even possible to achieve a material buildup during processing. In our experiments, the polydispersity of the molar mass distribution remained nearly identical despite multiple extrusions. Thus, reactive extrusion makes it possible for the corresponding plastics to be processed several times without the molar mass decreasing. If a sufficiently pure material flow can be ensured during recycling, the number of possible reprocessings of the plastic can be significantly increased without the need to add virgin material.

3.
Front Bioeng Biotechnol ; 10: 1067467, 2022.
Article in English | MEDLINE | ID: mdl-36466343

ABSTRACT

Tacrolimus (FK506) is a macrolide widely used as immunosuppressant to prevent transplant rejection. Synthetic production of FK506 is not efficient and costly, whereas the biosynthesis of FK506 is complex and the level produced by the wild type strain, Streptomyces tsukubaensis, is very low. We therefore engineered FK506 biosynthesis and the supply of the precursor L-lysine to generate strains with improved FK506 yield. To increase FK506 production, first the intracellular supply of the essential precursor lysine was improved in the native host S. tsukubaensis NRRL 18488 by engineering the lysine biosynthetic pathway. Therefore, a feedback deregulated aspartate kinase AskSt* of S. tsukubaensis was generated by site directed mutagenesis. Whereas overexpression of AskSt* resulted only in a 17% increase in FK506 yield, heterologous overexpression of a feedback deregulated AskCg* from Corynebacterium glutamicum was proven to be more efficient. Combined overexpression of AskCg* and DapASt, showed a strong enhancement of the intracellular lysine pool following increase in the yield by approximately 73% compared to the wild type. Lysine is coverted into the FK506 building block pipecolate by the lysine cyclodeaminase FkbL. Construction of a ∆fkbL mutant led to a complete abolishment of the FK506 production, confirming the indispensability of this enzyme for FK506 production. Chemical complementation of the ∆fkbL mutant by feeding pipecolic acid and genetic complementation with fkbL as well as with other lysine cyclodeaminase genes (pipAf, pipASt, originating from Actinoplanes friuliensis and Streptomyces pristinaespiralis, respectively) completely restored FK506 production. Subsequently, FK506 production was enchanced by heterologous overexpression of PipAf and PipASp in S. tsukubaensis. This resulted in a yield increase by 65% compared to the WT in the presence of PipAf from A. friuliensis. For further rational yield improvement, the crystal structure of PipAf from A. friuliensis was determined at 1.3 Å resolution with the cofactor NADH bound and at 1.4 Å with its substrate lysine. Based on the structure the Ile91 residue was replaced by Val91 in PipAf, which resulted in an overall increase of FK506 production by approx. 100% compared to the WT.

4.
J Am Chem Soc ; 137(46): 14640-52, 2015 Nov 25.
Article in English | MEDLINE | ID: mdl-26505827

ABSTRACT

We target the gatekeeper MET146 of c-Jun N-terminal kinase 3 (JNK3) to exemplify the applicability of X···S halogen bonds in molecular design using computational, synthetic, structural and biophysical techniques. In a designed series of aminopyrimidine-based inhibitors, we unexpectedly encounter a plateau of affinity. Compared to their QM-calculated interaction energies, particularly bromine and iodine fail to reach the full potential according to the size of their σ-hole. Instead, mutation of the gatekeeper residue into leucine, alanine, or threonine reveals that the heavier halides can significantly influence selectivity in the human kinome. Thus, we demonstrate that, although the choice of halogen may not always increase affinity, it can still be relevant for inducing selectivity. Determining the crystal structure of the iodine derivative in complex with JNK3 (4X21) reveals an unusual bivalent halogen/chalcogen bond donated by the ligand and the back-pocket residue MET115. Incipient repulsion from the too short halogen bond increases the flexibility of Cε of MET146, whereas the rest of the residue fails to adapt being fixed by the chalcogen bond. This effect can be useful to induce selectivity, as the necessary combination of methionine residues only occurs in 9.3% of human kinases, while methionine is the predominant gatekeeper (39%).


Subject(s)
Chalcogens/chemistry , Halogens/chemistry , Methionine/metabolism , Mitogen-Activated Protein Kinase 10/chemistry , Crystallography, X-Ray , Fluorescence Polarization
5.
J Neurochem ; 111(3): 703-15, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19712061

ABSTRACT

Mutations in the gene encoding leucine-rich repeat kinase 2 (LRRK2) are the most common cause of autosomal-dominant familial and late-onset sporadic Parkinson's disease (PD). LRRK2 is a large multi-domain protein featuring a GTP-binding C-terminal of Ras of complex proteins (ROC) (ROCO) domain combination unique for the ROCO protein family, directly followed by a kinase domain. Dimerization is a well-established phenomenon among protein kinases. Here, we confirm LRRK2 self-interaction, and provide evidence for general homo- and heterodimerization potential among the ROCO kinase family (LRRK2, LRRK1, and death-associated protein kinase 1). The ROCO domain was critically, though not exclusively involved in dimerization, as a LRRK2 deletion mutant lacking the ROCO domain retained dimeric properties. GTP binding did not appear to influence ROCO(LRRK2) self-interaction. Interestingly, ROCO(LRRK2) fragments exerted an inhibitory effect on both wild-type and the elevated G2019S LRRK2 autophosphorylation activity. Insertion of PD mutations into ROCO(LRRK2) reduced self-interaction and led to a reduction of LRRK2 kinase inhibition. Collectively, these results suggest a functional link between ROCO interactions and kinase activity of wild-type and mutant LRRK2. Importantly, our finding of ROCO(LRRK2) fragment-mediated LRRK2 kinase inhibition offers a novel lead for drug design and thus might have important implications for new therapeutic avenues in PD.


Subject(s)
Protein Multimerization/genetics , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/metabolism , Apoptosis Regulatory Proteins/chemistry , Apoptosis Regulatory Proteins/genetics , Apoptosis Regulatory Proteins/metabolism , Calcium-Calmodulin-Dependent Protein Kinases/chemistry , Calcium-Calmodulin-Dependent Protein Kinases/genetics , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Cell Line, Transformed , Death-Associated Protein Kinases , Dimerization , Humans , Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 , Lipids/genetics , Mutation/genetics , Protein Conformation , Protein Serine-Threonine Kinases/chemistry , Protein Structure, Tertiary/genetics , Signal Transduction/genetics , Transfection/methods , Two-Hybrid System Techniques
6.
Proc Natl Acad Sci U S A ; 106(34): 14309-14, 2009 Aug 25.
Article in English | MEDLINE | ID: mdl-19706516

ABSTRACT

Ergot alkaloids are toxins and important pharmaceuticals that are produced biotechnologically on an industrial scale. The first committed step of ergot alkaloid biosynthesis is catalyzed by dimethylallyl tryptophan synthase (DMATS; EC 2.5.1.34). Orthologs of DMATS are found in many fungal genomes. We report here the x-ray structure of DMATS, determined at a resolution of 1.76 A. A complex of DMATS from Aspergillus fumigatus with its aromatic substrate L-tryptophan and with an analogue of its isoprenoid substrate dimethylallyl diphosphate reveals the structural basis of this enzyme-catalyzed Friedel-Crafts reaction, which shows strict regiospecificity for position 4 of the indole nucleus of tryptophan as well as unusual independence of the presence of Mg(2+) ions. The 3D structure of DMATS belongs to a rare beta/alpha barrel fold, called prenyltransferase barrel, that was recently discovered in a small group of bacterial enzymes with no sequence similarity to DMATS. These bacterial enzymes catalyze the prenylation of aromatic substrates in the biosynthesis of secondary metabolites (i.e., a reaction similar to that of DMATS).


Subject(s)
Alkyl and Aryl Transferases/metabolism , Aspergillus fumigatus/enzymology , Dimethylallyltranstransferase/metabolism , Fungal Proteins/metabolism , Alkyl and Aryl Transferases/chemistry , Alkyl and Aryl Transferases/genetics , Amino Acid Sequence , Aspergillus fumigatus/genetics , Bacteria/enzymology , Catalysis , Catalytic Domain , Crystallography, X-Ray , Dimethylallyltranstransferase/chemistry , Dimethylallyltranstransferase/genetics , Fungal Proteins/chemistry , Fungal Proteins/genetics , Fungi/enzymology , Hemiterpenes/chemistry , Hemiterpenes/metabolism , Magnesium/chemistry , Models, Chemical , Models, Molecular , Molecular Sequence Data , Molecular Structure , Organophosphorus Compounds/chemistry , Organophosphorus Compounds/metabolism , Protein Structure, Tertiary , Sequence Homology, Amino Acid , Substrate Specificity , Terpenes/chemistry , Terpenes/metabolism , Tryptophan/chemistry , Tryptophan/metabolism
7.
J Biol Chem ; 284(21): 14245-57, 2009 May 22.
Article in English | MEDLINE | ID: mdl-19293155

ABSTRACT

Parkinson disease (PD)-associated genomic deletions and the destabilizing L166P point mutation lead to loss of the cytoprotective DJ-1 protein. The effects of other PD-associated point mutations are less clear. Here we demonstrate that the M26I mutation reduces DJ-1 expression, particularly in a null background (knockout mouse embryonic fibroblasts). Thus, homozygous M26I mutation causes loss of DJ-1 protein. To determine the cellular consequences, we measured suppression of apoptosis signal-regulating kinase 1 (ASK1) and cytotoxicity for [M26I]DJ-1, and systematically all other DJ-1 methionine and cysteine mutants. C106A mutation of the central redox site specifically abolished binding to ASK1 and the cytoprotective activity of DJ-1. DJ-1 was apparently recruited into the ASK1 signalosome via Cys-106-linked mixed disulfides. The designed higher order oxidation mimicking [C106DD]DJ-1 non-covalently bound to ASK1 even in the absence of hydrogen peroxide and conferred partial cytoprotection. Interestingly, mutations of peripheral redox sites (C46A and C53A) and M26I also led to constitutive ASK1 binding. Cytoprotective [wt]DJ-1 bound to the ASK1 N terminus (which is known to bind another negative regulator, thioredoxin 1), whereas [M26I]DJ-1 bound to aberrant C-terminal site(s). Consequently, the peripheral cysteine mutants retained cytoprotective activity, whereas the PD-associated mutant [M26I]DJ-1 failed to suppress ASK1 activity and nuclear export of the death domain-associated protein Daxx and did not promote cytoprotection. Thus, cytoprotective binding of DJ-1 to ASK1 depends on the central redox-sensitive Cys-106 and may be modulated by peripheral cysteine residues. We suggest that impairments in oxidative conformation changes of DJ-1 might contribute to PD neurodegeneration.


Subject(s)
Amino Acids/metabolism , Apoptosis , Cytoprotection , MAP Kinase Kinase Kinase 5/metabolism , Oncogene Proteins/metabolism , Active Transport, Cell Nucleus/drug effects , Amino Acid Substitution/drug effects , Animals , Apoptosis/drug effects , Cell Line , Cell Nucleus/drug effects , Cell Nucleus/metabolism , Cytoprotection/drug effects , Disulfides/metabolism , Humans , Hydrogen Peroxide/pharmacology , Mice , Models, Biological , Mutagenesis/drug effects , Mutation/genetics , Nuclear Proteins/metabolism , Oxidation-Reduction/drug effects , Oxidative Stress/drug effects , Parkinson Disease/metabolism , Peroxiredoxins , Protein Binding/drug effects , Protein Deglycase DJ-1 , Protein Multimerization/drug effects , Protein Stability/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...